Bristol-Myers Squibb Co. v. F.H. Faulding & Co. Ltd., FCA 316, 170 ALR 439, Australia, 2000
In this case, the Australian Federal Court addressed the patentability of methods of treatment of the human body, how novelty can be destroyed and what amounts to secondary infringement.
Case Summary
Decision Link